NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 818 filers reported holding NOVARTIS A G in Q4 2013. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $730 | -70.7% | 7,557 | -69.4% | 0.04% | -69.9% |
| Q4 2023 | $2,494 | +1054.6% | 24,704 | +1063.1% | 0.14% | +333.3% |
| Q3 2023 | $216 | -100.0% | 2,124 | -92.6% | 0.03% | -86.1% |
| Q2 2021 | $2,624,000 | -40.8% | 28,768 | -38.5% | 0.24% | +76.9% |
| Q4 2019 | $4,429,000 | -30.6% | 46,778 | -36.3% | 0.13% | -60.7% |
| Q3 2019 | $6,379,000 | +71.0% | 73,412 | +48.6% | 0.34% | +342.9% |
| Q2 2018 | $3,731,000 | +203.1% | 49,400 | +216.7% | 0.08% | +87.8% |
| Q3 2016 | $1,231,000 | +145.2% | 15,600 | +205.9% | 0.04% | -14.6% |
| Q1 2015 | $502,000 | -26.7% | 5,100 | -31.1% | 0.05% | -54.7% |
| Q4 2014 | $685,000 | +19.3% | 7,400 | +21.3% | 0.11% | -4.5% |
| Q3 2014 | $574,000 | -44.2% | 6,100 | -49.6% | 0.11% | +126.5% |
| Q1 2014 | $1,028,000 | +14.2% | 12,100 | +8.0% | 0.05% | -43.7% |
| Q4 2013 | $900,000 | +86.3% | 11,200 | +77.8% | 0.09% | +102.3% |
| Q3 2013 | $483,000 | – | 6,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
| MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
| SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
| SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
| SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
| First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
| PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
| GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
| Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
| WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |